<DOC>
	<DOC>NCT01654354</DOC>
	<brief_summary>Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) with Ultravist 370 INJ.(Iopromide 768.86mg) in abdominal CT</brief_summary>
	<brief_title>Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT</brief_title>
	<detailed_description />
	<criteria>Aged 20 to 75 years old. Subjects who need CT scan Subjects who are willing to participate in the study and to write the informed consent form. Subjects with severe hepatopathy whose AST or ALT ≥ 1,000 IU/L, Subjects with liver cirrhosis whose AST or ALT ≥ UNL(upper normal limit) X 3 Severe disorder of thyroid gland homocystinuria pregnant or breastfeeding female subjects, or female subjects with childbearing potential who are not willing to use proper contraception methods Participation in another clinical trial within 30days of enrollment into this study.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Qualitative Evaluation of abdominal CT image using 4 point scale: Excellent(4)/ Good(3) / Fair(2) / Unacceptable(1)</keyword>
</DOC>